Stroke, including cerebral ischemia, intracerebral hemorrhage, and subarachnoid hemorrhage, is the leading cause of long-term disability and death worldwide. Animal models have greatly contributed to our understanding...Stroke, including cerebral ischemia, intracerebral hemorrhage, and subarachnoid hemorrhage, is the leading cause of long-term disability and death worldwide. Animal models have greatly contributed to our understanding of the risk factors and the pathophysiology of stroke, as well as the development of therapeutic strategies for its treatment. Further development and investigation of experimental models, however, are needed to elucidate the pathogenesis of stroke and to enhance and expand novel therapeutic targets. In this article, we provide an overview of the characteristics of commonly-used animal models of stroke and focus on the inflammatory responses to cerebral stroke, which may provide insights into a framework for developing effective therapies for stroke in humans.展开更多
Purpose:Thalamic hemorrhage breaking into ventricles(THBIV)is a devastating disease with high morbidity and mortality rates.Endoscopic surgery(ES)may improve outcomes,although there is no consensus on its superiority....Purpose:Thalamic hemorrhage breaking into ventricles(THBIV)is a devastating disease with high morbidity and mortality rates.Endoscopic surgery(ES)may improve outcomes,although there is no consensus on its superiority.We investigated the efficacy and safety of ES and compared the outcomes of different management strategies by ES,hematoma puncture and drainage(HPD),and external ventricular drainage(EVD)in patients with THBIV.Methods:We retrospectively analyzed patients with THBIV treated by ES,HPD,or EVD at our hospital from June 2015 to June 2018.Patients were categorized into anteromedial and posterolateral groups based on THBIV location,and then the two groups were further divided into ES,HPD,and EVD subgroups.Individualized surgical approach was adopted according to the location of the hematoma in the ES subgroups.Patient characteristics and surgical outcomes were investigated.Results:We analyzed 211 consecutive patients.There were no significant differences in clinical characteristics or incidence of perioperative procedure-related complications(postoperative rebleeding and intracranial infection)in either anteromedial or posterolateral groups.Compared with other therapeutic methods,the ES subgroups had the highest hematoma evacuation rate,shortest drainage time,and lowest incidence of chronic ventricular dilatation(all p<0.05).Among the three anteromedial subgroups,ES subgroup had the best clinical outcomes which was assessed by the modified Rankin Scale,followed by HPD and EVD subgroups(p<0.01);while in the posterolateral subgroups,clinical outcomes in the ES and HPD subgroups were similar and better than that in the EVD subgroup(p=0.037).Conclusion:Individualized surgical ES approach for removal of thalamic and ventricular hematomas is a minimally invasive,safe,and effective strategy for the treatment of THBIV with a thalamic hematoma volume of 10-30 mL.展开更多
目的:通过系列临床研究,体现我科中医药治疗急性脑出血的独特临床优势,并验证我科中医中风病诊疗方案的科学性、实用性、可重复性及可操作性。方法:将120例急性脑出血患者随机分为西医治疗组和中西医结合治疗组。通过对治疗前后血超氧...目的:通过系列临床研究,体现我科中医药治疗急性脑出血的独特临床优势,并验证我科中医中风病诊疗方案的科学性、实用性、可重复性及可操作性。方法:将120例急性脑出血患者随机分为西医治疗组和中西医结合治疗组。通过对治疗前后血超氧化物歧化酶(Superoxide Dismutase,SOD)、脂质过氧化物血清丙二醛(MDA)、C反应蛋白(C-reacti Ve Protein,CRP)、同型半胱氨酸(Homocysteine,HCY)指标的比较,分析比较2组患者之间在近期疗效方面的差异;通过对2组患者之间治疗前后的神经功能缺损评分、Barthel指数的比较,分析评价它们之间远期疗效的优劣。结果:近期指标:中西医结合治疗组的MDA、CRP、HCY比西医治疗组有明显下降(P<0.05),SOD升高(P<0.05),优于西医治疗组。远期指标:中西医结合治疗组的神经功能缺损评分减低、Barthel指数提高比西医治疗组差异有统计学意义(P<0.05)。结论:中西医结合治疗急性出血性脑卒中比单纯西医治疗有明显的优势。展开更多
基金supported by grants from National Institute on Aging (R01 AG031811, R01 AG037506)National Institute of Neurological Disorders and Stroke (R01 NS083078-01A1, R41 NS080329-01A1)+1 种基金American Heart Association grant (14GRNT20460026)the National Natural Science Foundation of China (81300993, 81571145)
文摘Stroke, including cerebral ischemia, intracerebral hemorrhage, and subarachnoid hemorrhage, is the leading cause of long-term disability and death worldwide. Animal models have greatly contributed to our understanding of the risk factors and the pathophysiology of stroke, as well as the development of therapeutic strategies for its treatment. Further development and investigation of experimental models, however, are needed to elucidate the pathogenesis of stroke and to enhance and expand novel therapeutic targets. In this article, we provide an overview of the characteristics of commonly-used animal models of stroke and focus on the inflammatory responses to cerebral stroke, which may provide insights into a framework for developing effective therapies for stroke in humans.
文摘Purpose:Thalamic hemorrhage breaking into ventricles(THBIV)is a devastating disease with high morbidity and mortality rates.Endoscopic surgery(ES)may improve outcomes,although there is no consensus on its superiority.We investigated the efficacy and safety of ES and compared the outcomes of different management strategies by ES,hematoma puncture and drainage(HPD),and external ventricular drainage(EVD)in patients with THBIV.Methods:We retrospectively analyzed patients with THBIV treated by ES,HPD,or EVD at our hospital from June 2015 to June 2018.Patients were categorized into anteromedial and posterolateral groups based on THBIV location,and then the two groups were further divided into ES,HPD,and EVD subgroups.Individualized surgical approach was adopted according to the location of the hematoma in the ES subgroups.Patient characteristics and surgical outcomes were investigated.Results:We analyzed 211 consecutive patients.There were no significant differences in clinical characteristics or incidence of perioperative procedure-related complications(postoperative rebleeding and intracranial infection)in either anteromedial or posterolateral groups.Compared with other therapeutic methods,the ES subgroups had the highest hematoma evacuation rate,shortest drainage time,and lowest incidence of chronic ventricular dilatation(all p<0.05).Among the three anteromedial subgroups,ES subgroup had the best clinical outcomes which was assessed by the modified Rankin Scale,followed by HPD and EVD subgroups(p<0.01);while in the posterolateral subgroups,clinical outcomes in the ES and HPD subgroups were similar and better than that in the EVD subgroup(p=0.037).Conclusion:Individualized surgical ES approach for removal of thalamic and ventricular hematomas is a minimally invasive,safe,and effective strategy for the treatment of THBIV with a thalamic hematoma volume of 10-30 mL.
文摘目的:通过系列临床研究,体现我科中医药治疗急性脑出血的独特临床优势,并验证我科中医中风病诊疗方案的科学性、实用性、可重复性及可操作性。方法:将120例急性脑出血患者随机分为西医治疗组和中西医结合治疗组。通过对治疗前后血超氧化物歧化酶(Superoxide Dismutase,SOD)、脂质过氧化物血清丙二醛(MDA)、C反应蛋白(C-reacti Ve Protein,CRP)、同型半胱氨酸(Homocysteine,HCY)指标的比较,分析比较2组患者之间在近期疗效方面的差异;通过对2组患者之间治疗前后的神经功能缺损评分、Barthel指数的比较,分析评价它们之间远期疗效的优劣。结果:近期指标:中西医结合治疗组的MDA、CRP、HCY比西医治疗组有明显下降(P<0.05),SOD升高(P<0.05),优于西医治疗组。远期指标:中西医结合治疗组的神经功能缺损评分减低、Barthel指数提高比西医治疗组差异有统计学意义(P<0.05)。结论:中西医结合治疗急性出血性脑卒中比单纯西医治疗有明显的优势。
